HomeNewsIndiaCOVID-19 | Private healthcare centres can take 'service charge' up to Rs 100 per vaccination

COVID-19 | Private healthcare centres can take 'service charge' up to Rs 100 per vaccination

Vaccines to private centres will be provided by the government itself, or they can avail the vaccine from public hospitals having cold storage facilities.

February 26, 2021 / 23:36 IST
Story continues below Advertisement
File image: A healthcare worker holding a rose receives an AstraZeneca's COVISHIELD vaccine, during the COVID-19 vaccination campaign, at a medical centre in Mumbai, India on January 16, 2021. (Image: Reuters/Francis Mascarenhas)
File image: A healthcare worker holding a rose receives an AstraZeneca's COVISHIELD vaccine, during the COVID-19 vaccination campaign, at a medical centre in Mumbai, India on January 16, 2021. (Image: Reuters/Francis Mascarenhas)

Private facilities can collect a "service charge" of up to Rs 100 from the beneficiaries to meet the operational expenses they will be incurring during the vaccination drive against COVID-19. This will be in addition to the cost of the vaccines, government sources told IANS on February 26.

This decision was taken factoring inputs from major private healthcare brands.

Story continues below Advertisement

"Whatever is the cost the vaccine provided to them, they (private facilities) will have a band of Rs 100 to incur the operational cost of the vaccines which includes syringes, needles, manpower etc.," reported IANS, adding that the government has clarified that the private centres will not be allowed to charge more than Rs 100 (plus cost of the dose) from the beneficiaries.

Vaccines to private centres will be provided by the government itself, or they can avail the vaccine from public hospitals having cold storage facilities.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show